Health Care Innovation
			Drug Pricing				
			
		NEW BRIEF: Mandating that Drug Rebates Benefit Consumers Will Help Patients with High Out-of-Pocket Drug Costs
			A new brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute found that reforms mandating drug rebates benefit patients rather than payers would lower overall health care costs and help patients with expensive out-of-pocket drug costs. Click here to download the brief “Ironically, ...		
					
					
			
																				
			Wayne Winegarden		
				
																						
			September 29, 2020		
				
					
			Commentary				
			
		Price Controls Are Disastrous For Rents And Will Be For Drugs
			President Trump and senior advisor Jared Kushner claim that the most favored nation executive order signed by the President over the weekend is necessary for drug pricing because “the U.S. shouldn’t pay more than other European countries for the same treatments.” This policy will make things worse, not better. If the president ...		
					
					
			
																				
			Wayne Winegarden		
				
																						
			September 15, 2020		
				
					
			Commentary				
			
		Trump’s Drug Pricing Order Is A Costly Mistake
			On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...		
					
					
			
																				
			Sally C. Pipes		
				
																						
			September 15, 2020		
				
					
			Blog				
			
		California Entering Pharmaceutical Business Won’t Lower Drug Prices for Patients
			The state of California, which can’t keep the lights on thanks to political interference in energy generation, nor build enough homes because government has poisoned the housing market, is going into the pharmaceutical manufacturing business. But there’s nothing to worry about. If it struggles, taxpayers will be there to bail ...		
					
					
			
																				
			Kerry Jackson		
				
																						
			September 9, 2020		
				
					
			Health Care				
			
		PRI Medical Billing Study Featured in Northern California Record
			Title: AB 72 brief analyzes impact of medical billing reform law that’s had bad consequences for patients and practitioners By Sarah Downey, Northern California Record A new policy brief about the impact of California AB 72 finds that the law – designed to alleviate surprise medical billing – while well-intentioned ...		
					
					
			
																				
			Pacific Research Institute		
				
																						
			September 3, 2020		
				
					
			California				
			
		Read Revcycle Intelligence Story on Surprise Medical Billing Brief
			Surprise Billing Price Controls Decreasing Care Quality in CA By: Jacqueline LaPointe, Reporter Researchers at the Pacific Research Institute are warning Congressmembers to steer clear from price controls as a solution for surprise billing after finding that the policy approach had unintended consequences in California. In a new brief, researchers found ...		
					
					
			
																				
			Pacific Research Institute		
				
																						
			August 24, 2020		
				
					
			California				
			
		New Brief Shows Impact of California’s Surprise Medical Billing Law: Lower Quality Care, Reduced Access, Higher System Costs
			California’s surprise medical billing law (Assembly Bill 72) – which imposes price controls on the rates out-of-network physicians can charge at in-network facilities – is hurting patients with lower quality care, reduced access, and higher health care system costs, finds a new brief released today by the Center for Medical ...		
					
					
			
																				
			Wayne Winegarden		
				
																						
			August 19, 2020		
				
					
			Commentary				
			
		Kamala Harris’s harrowing healthcare history
			Sen. Kamala Harris will be the Democratic Party’s nominee for vice president, we learned on Tuesday. The pick appears to be in line with former Vice President Joe Biden’s semi-moderate instincts. But on healthcare, Harris has proved anything but moderate. She has a long track record of support for government-run healthcare. ...		
					
					
			
																				
			Sally C. Pipes		
				
																						
			August 13, 2020		
				
					
			Commentary				
			
		Trump’s drug pricing executive orders harmful to patients — will hinder development of new drugs
			President Trump issued four executive orders Friday that he said will lower drug prices — but in reality, three of the orders will cause far more harm than good and represent electioneering at its worst. The three harmful executive orders allow the importation of drugs from Canada, reduce the price ...		
					
					
			
																				
			Sally C. Pipes		
				
																						
			July 24, 2020		
				
					
			Commentary				
			
		President Trump’s Big Government Instincts Threaten Drug Innovation And Availability
			President Reagan famously said, “the nine most terrifying words in the English language are: I’m from the Government and I’m here to help”. It is time for President Trump to learn this wisdom. Along with Speaker Pelosi, Senator Sanders, and Representative Ocasio-Cortez, President Trump seems to believe that giving the ...		
					
					
			
																				
			Wayne Winegarden		
				
																						
			July 24, 2020		
				
					NEW BRIEF: Mandating that Drug Rebates Benefit Consumers Will Help Patients with High Out-of-Pocket Drug Costs
			A new brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute found that reforms mandating drug rebates benefit patients rather than payers would lower overall health care costs and help patients with expensive out-of-pocket drug costs. Click here to download the brief “Ironically, ...		
					Price Controls Are Disastrous For Rents And Will Be For Drugs
			President Trump and senior advisor Jared Kushner claim that the most favored nation executive order signed by the President over the weekend is necessary for drug pricing because “the U.S. shouldn’t pay more than other European countries for the same treatments.” This policy will make things worse, not better. If the president ...		
					Trump’s Drug Pricing Order Is A Costly Mistake
			On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...		
					California Entering Pharmaceutical Business Won’t Lower Drug Prices for Patients
			The state of California, which can’t keep the lights on thanks to political interference in energy generation, nor build enough homes because government has poisoned the housing market, is going into the pharmaceutical manufacturing business. But there’s nothing to worry about. If it struggles, taxpayers will be there to bail ...		
					PRI Medical Billing Study Featured in Northern California Record
			Title: AB 72 brief analyzes impact of medical billing reform law that’s had bad consequences for patients and practitioners By Sarah Downey, Northern California Record A new policy brief about the impact of California AB 72 finds that the law – designed to alleviate surprise medical billing – while well-intentioned ...		
					Read Revcycle Intelligence Story on Surprise Medical Billing Brief
			Surprise Billing Price Controls Decreasing Care Quality in CA By: Jacqueline LaPointe, Reporter Researchers at the Pacific Research Institute are warning Congressmembers to steer clear from price controls as a solution for surprise billing after finding that the policy approach had unintended consequences in California. In a new brief, researchers found ...		
					New Brief Shows Impact of California’s Surprise Medical Billing Law: Lower Quality Care, Reduced Access, Higher System Costs
			California’s surprise medical billing law (Assembly Bill 72) – which imposes price controls on the rates out-of-network physicians can charge at in-network facilities – is hurting patients with lower quality care, reduced access, and higher health care system costs, finds a new brief released today by the Center for Medical ...		
					Kamala Harris’s harrowing healthcare history
			Sen. Kamala Harris will be the Democratic Party’s nominee for vice president, we learned on Tuesday. The pick appears to be in line with former Vice President Joe Biden’s semi-moderate instincts. But on healthcare, Harris has proved anything but moderate. She has a long track record of support for government-run healthcare. ...		
					Trump’s drug pricing executive orders harmful to patients — will hinder development of new drugs
			President Trump issued four executive orders Friday that he said will lower drug prices — but in reality, three of the orders will cause far more harm than good and represent electioneering at its worst. The three harmful executive orders allow the importation of drugs from Canada, reduce the price ...		
					President Trump’s Big Government Instincts Threaten Drug Innovation And Availability
			President Reagan famously said, “the nine most terrifying words in the English language are: I’m from the Government and I’m here to help”. It is time for President Trump to learn this wisdom. Along with Speaker Pelosi, Senator Sanders, and Representative Ocasio-Cortez, President Trump seems to believe that giving the ...		
					